1. Home
  2. CSTL vs HRTG Comparison

CSTL vs HRTG Comparison

Compare CSTL & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • HRTG
  • Stock Information
  • Founded
  • CSTL 2007
  • HRTG 2012
  • Country
  • CSTL United States
  • HRTG United States
  • Employees
  • CSTL N/A
  • HRTG N/A
  • Industry
  • CSTL Medical Specialities
  • HRTG Property-Casualty Insurers
  • Sector
  • CSTL Health Care
  • HRTG Finance
  • Exchange
  • CSTL Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • CSTL 555.8M
  • HRTG 590.0M
  • IPO Year
  • CSTL 2019
  • HRTG 2014
  • Fundamental
  • Price
  • CSTL $24.21
  • HRTG $23.41
  • Analyst Decision
  • CSTL Strong Buy
  • HRTG Buy
  • Analyst Count
  • CSTL 6
  • HRTG 3
  • Target Price
  • CSTL $37.67
  • HRTG $29.00
  • AVG Volume (30 Days)
  • CSTL 712.7K
  • HRTG 472.2K
  • Earning Date
  • CSTL 08-04-2025
  • HRTG 08-05-2025
  • Dividend Yield
  • CSTL N/A
  • HRTG N/A
  • EPS Growth
  • CSTL N/A
  • HRTG 76.20
  • EPS
  • CSTL N/A
  • HRTG 3.47
  • Revenue
  • CSTL $346,269,000.00
  • HRTG $841,666,000.00
  • Revenue This Year
  • CSTL N/A
  • HRTG $5.15
  • Revenue Next Year
  • CSTL N/A
  • HRTG $6.80
  • P/E Ratio
  • CSTL N/A
  • HRTG $6.69
  • Revenue Growth
  • CSTL 20.40
  • HRTG 9.57
  • 52 Week Low
  • CSTL $14.59
  • HRTG $8.70
  • 52 Week High
  • CSTL $35.84
  • HRTG $26.64
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 76.51
  • HRTG 60.01
  • Support Level
  • CSTL $20.35
  • HRTG $21.51
  • Resistance Level
  • CSTL $20.80
  • HRTG $23.48
  • Average True Range (ATR)
  • CSTL 0.95
  • HRTG 0.83
  • MACD
  • CSTL 0.45
  • HRTG 0.16
  • Stochastic Oscillator
  • CSTL 96.67
  • HRTG 97.23

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

Share on Social Networks: